News Room

1 - 10 of 2004

FDA Approves Drug for Rare Cancer

Published on in CHOP News

CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.

2022 Disability Equality Index Names CHOP a “Best Place to Work for Disability Inclusion”

Published on in CHOP News

2022 DEI Badge 100 score

Children’s Hospital of Philadelphia (CHOP) has been recognized by the 2022 Disability Equality Index (DEI) as a leader in “Best Places to Work for Disability Inclusion.” The DEI is the nation’s most comprehensive annual benchmarking tool used to survey employers’ disability policies, practices, and initiatives. For the fourth year in a row, CHOP received a 100 out of 100 score, the DEI’s highest ranking.

CHOP Partners with Eastern Minority Supplier Development Council to Host Matchmaker Event Targeted Towards Construction, Facilities and Building Trades

Published on in CHOP News

CHOP partnered with the Eastern Minority Supplier Development Council to host its first matchmaker event targeted towards construction, facilities and building trades. The virtual event offered attendees the opportunity to learn more about CHOP, our supplier diversity program, future bid opportunities, and to meet with CHOP’s senior leaders, facilities and construction teams.

News Archive Search

Can't find what you are looking for? Search the news archives.